Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management: A subanalysis of the JPAD trial

OBJECTIVE: Recent reports showed that low-dose aspirin was ineffective in the primary prevention of cardiovascular events in diabetic patients overall. We hypothesized that low-dose aspirin would be beneficial in patients receiving insulin therapy, as a high-risk group. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Sadanori, Morimoto, Takeshi, Ogawa, Hisao, Kanauchi, Masao, Nakayama, Masafumi, Uemura, Shiro, Doi, Naofumi, Jinnouchi, Hideaki, Waki, Masako, Soejima, Hirofumi, Sakuma, Mio, Saito, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114321/
https://www.ncbi.nlm.nih.gov/pubmed/21515838
http://dx.doi.org/10.2337/dc10-2451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114321/
https://www.ncbi.nlm.nih.gov/pubmed/21515838
http://dx.doi.org/10.2337/dc10-2451

Ejemplares similares